About the Authors
- Kristin L. Griffiths
-
Affiliation Jenner Institute, University of Oxford, Oxford, United Kingdom
- Elena Stylianou
-
Affiliation Jenner Institute, University of Oxford, Oxford, United Kingdom
- Hazel C. Poyntz
-
Affiliation Jenner Institute, University of Oxford, Oxford, United Kingdom
- Gareth J. Betts
-
Affiliation Jenner Institute, University of Oxford, Oxford, United Kingdom
- Helen A. Fletcher
-
Affiliation Jenner Institute, University of Oxford, Oxford, United Kingdom
- Helen McShane
-
* E-mail: helen.mcshane@ndm.ox.ac.uk
Affiliation Jenner Institute, University of Oxford, Oxford, United Kingdom
Competing Interests
The authors have read the journal's policy and have the following conflicts: HM is a named inventor in a patent filing related to MVA85A and is a shareholder in a joint venture, OETC, formed for the future development of this vaccine. HM is named as a co-inventor on patents related to heterologous prime-boost immunization. There are no other conflicts of interest. These conflicts of interest will not in any way interfere with the authors' adherence to the journal's policies on sharing data and materials. Below are the relevant patent details as requested following review: MVA patent: International Application Number: PCT/GB2006/000023 Title: “Compositions for immunizing against Mycobacterium” Prime/boost patent: International publication number: WO/02 24224 A2 Title: Vaccination method.
Author Contributions
Conceived and designed the experiments: KLG HAF HM. Performed the experiments: KLG ES HCP GJB. Analyzed the data: KLG HM. Contributed reagents/materials/analysis tools: KLG ES. Wrote the paper: KLG.